German medtech company BIOTRONIK has announced the market release of Solia CSP S, the latest addition to its growing portfolio of Conduction System Pacing (CSP) solutions and the world’s first pacing lead to combine a fixed screw design with a stylet-driven implantation approach.

According to BIOTRONIK, the device is designed to simplify CSP procedures while enhancing control and precision. The fixed screw design reduces preparation time while the stylet enables high steerability and continuous electrical measurements.

The first commercial implants were successfully performed by Dr. Óscar Cano at the University and Polytechnic La Fe Hospital of Valencia, Spain.

“In my experience, the stylet-driven Solia CSP S together with the Selectra 3D catheter enabled good alignment with the septal wall and it was easy to penetrate the septum. The procedures went very fast, and we had only minimal use of fluoroscopy,” said Dr. Cano.

Andreas Hecker, President CRM/EP at BIOTRONIK, said, “The launch of Solia CSP S represents a step forward in making CSP procedures more accessible and efficient. It is part of our ongoing commitment to physiologic pacing and providing physicians with tools that streamline implantation for better patient outcomes.”

Conduction System Pacing is increasingly viewed as a new standard of care in cardiac device therapy, with growing demand for dedicated tools.

“The challenge in cardiac rhythm management today is to treat more patients while maintaining the highest standards of care. Tools like BIOTRONIK’s CSP solution help us deliver physiologic pacing while keeping workflows lean and manageable,” said Dr. Joaquín Osca Asensi, Head of the Arrhythmia Unit at La Fe Hospital of Valencia, Spain.